Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >Pharmaceutical intermediates >Heterocyclic compound >Pyran compounds >Centchroman

Centchroman

Centchroman Structure
  • ₹10078.08 - ₹40637.05
  • Product name: Centchroman
  • CAS: 31477-60-8
  • MF: C30H35NO3
  • MW: 457.6
  • EINECS:256-846-9
  • MDL Number:
  • Synonyms:Centchroman;1-[2-[p-(trans-7-Methoxy-2,2-diMethyl-3-phenyl- 4-chroManyl)phenoxy]ethyl]pyrrolidine;3,4-trans-2,2-DiMethyl-3-phenyl-4-[p-(β- py;rel-1-[2-[4-[(3R,4R)-3,4-dihydro-7-Methoxy-2,2-diMethyl-3-phenyl-2H-1-benzopyran-4-yl]phenoxy]ethyl]pyrrolidine;Pyrrolidine, 1-[2-[4-[(3R,4R)-3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl]phenoxy]ethyl]-, rel-;Centchroman ISO 9001:2015 REACH
2 prices
Selected condition:

Brand

  • Sigma-Aldrich(India)

Package

  • 5MG
  • 25MG
  • ManufacturerSigma-Aldrich(India)
  • Product numberSML2237
  • Product descriptionOrmeloxifene ≥95% (HPLC)
  • Packaging5MG
  • Price₹10078.08
  • Updated2022-06-14
  • Buy
  • ManufacturerSigma-Aldrich(India)
  • Product numberSML2237
  • Product descriptionOrmeloxifene ≥95% (HPLC)
  • Packaging25MG
  • Price₹40637.05
  • Updated2022-06-14
  • Buy
Manufacturer Product number Product description Packaging Price Updated Buy
Sigma-Aldrich(India) SML2237 Ormeloxifene ≥95% (HPLC) 5MG ₹10078.08 2022-06-14 Buy
Sigma-Aldrich(India) SML2237 Ormeloxifene ≥95% (HPLC) 25MG ₹40637.05 2022-06-14 Buy

Properties

Melting point :99-101°
Boiling point :563.39°C (rough estimate)
Density :1.1065 (rough estimate)
refractive index :1.6310 (estimate)
storage temp. :2-8°C
solubility :Soluble in DMSO
pka :9.61±0.20(Predicted)
form :oil
color :colorless to light brown

Safety Information

Symbol(GHS):
Signal word:
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
Precautionary statements:

Description

Centchroman is a new, weekly, orally active contraceptive with weak estrogenic and potent antiestrogenic properties.It is reported to be the first non-hormonal, non-steroidal oral contraceptive. Centchroman acts by inhibiting the implantation of fertilized eggs in the uterus. With the exception of longer menstrual cycles, no side effects have been reported. Another indication under study is the treatment of hormone dependent breast cancer.

Related product price